Aurobindo Pharma Limited, Unit VII

Form 483

Jedcherla Mandal, Mahabubnagar, -, IndiaFEI 3007373532Issued February 10, 2026

View Form 483 PDF

Source: FDA, document on file. FDA released the Form 483 itself. The document linked above is our copy of FDA's file, stored by us so the link cannot break, and FDA's own copy is linked beside it. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3007373532.

Observations9

Issue DateFebruary 10, 2026

StatusWarning Letter Issued

Establishment TypeFinished Drug Product Manufacturer

Related Inspections7

Establishment Details

Firm: Aurobindo Pharma Limited, Unit VII
Location: Jedcherla Mandal, Mahabubnagar, -, India
FEI Number: 3007373532
Establishment Type: Finished Drug Product Manufacturer
Product Type: Drugs
Issue Date: February 10, 2026
Country: India

Inspection History, 2009 to 2022

NAI4

VAI2

OAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Aurobindo Pharma Limited, Unit VII FDA Form 483, Jedcherla Mandal, Mahabubnagar, February 10, 2026